Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 198Unknown 61Terminated 37Recruiting 30Active not recruiting 25Withdrawn 8Suspended 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Chemotherapeutic Agent Toxicity 1Advanced Cancer 1

Interventions

Specimen Handling 29Magnetic Resonance Spectroscopy 18Biopsy 16Cyclophosphamide 15Nivolumab 10Paclitaxel 9Vincristine 8Cisplatin 8venetoclax 7Prednisone 7Gemcitabine 7Doxorubicin 7Bevacizumab 7Azacitidine 7pembrolizumab 6Radiotherapy 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Rituximab 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Injections 5Everolimus 5Capecitabine 5fludarabine phosphate 4Taxes 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Interventional × Ifosfamide × Clear all
NCT00695032 2014-11-05

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Institut Claudius Regaud

Phase NA Suspended
80 enrolled
Other solid neoplasm

Chemotherapeutic Agent Toxicity

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended
20 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡